GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Link Pharma Chem Ltd (BOM:524748) » Definitions » Cyclically Adjusted Revenue per Share

Link Pharma Chem (BOM:524748) Cyclically Adjusted Revenue per Share : ₹76.00 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Link Pharma Chem Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Link Pharma Chem's adjusted revenue per share for the three months ended in Dec. 2023 was ₹17.946. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹76.00 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Link Pharma Chem's average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-06), Link Pharma Chem's current stock price is ₹39.10. Link Pharma Chem's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₹76.00. Link Pharma Chem's Cyclically Adjusted PS Ratio of today is 0.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Link Pharma Chem was 0.95. The lowest was 0.37. And the median was 0.57.


Link Pharma Chem Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Link Pharma Chem's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Link Pharma Chem Cyclically Adjusted Revenue per Share Chart

Link Pharma Chem Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 61.90 69.81 75.46

Link Pharma Chem Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.47 75.46 76.72 76.49 76.00

Competitive Comparison of Link Pharma Chem's Cyclically Adjusted Revenue per Share

For the Chemicals subindustry, Link Pharma Chem's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Link Pharma Chem's Cyclically Adjusted PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Link Pharma Chem's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Link Pharma Chem's Cyclically Adjusted PS Ratio falls into.



Link Pharma Chem Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Link Pharma Chem's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=17.946/152.9243*152.9243
=17.946

Current CPI (Dec. 2023) = 152.9243.

Link Pharma Chem Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 8.518 91.425 14.248
201406 5.892 94.103 9.575
201409 13.250 96.780 20.937
201412 14.320 96.780 22.627
201503 6.121 97.163 9.634
201506 8.227 99.841 12.601
201509 5.110 101.753 7.680
201512 6.167 102.901 9.165
201603 9.712 102.518 14.487
201606 9.610 105.961 13.869
201609 8.311 105.961 11.995
201612 8.627 105.196 12.541
201703 8.623 105.196 12.535
201706 14.265 107.109 20.367
201709 12.687 109.021 17.796
201712 14.317 109.404 20.012
201803 12.023 109.786 16.747
201806 12.318 111.317 16.922
201809 19.756 115.142 26.239
201812 13.117 115.142 17.421
201903 9.524 118.202 12.322
201906 12.502 120.880 15.816
201909 13.979 123.175 17.355
201912 16.529 126.235 20.024
202003 13.193 124.705 16.178
202006 11.464 127.000 13.804
202009 21.126 130.118 24.829
202012 22.379 130.889 26.147
202103 25.367 131.771 29.439
202106 30.126 134.084 34.359
202109 33.454 135.847 37.659
202112 31.572 138.161 34.946
202203 25.450 138.822 28.035
202206 26.244 142.347 28.194
202209 19.035 144.661 20.122
202212 20.887 145.763 21.913
202303 20.884 146.865 21.746
202306 17.708 150.280 18.020
202309 13.626 151.492 13.755
202312 17.946 152.924 17.946

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Link Pharma Chem  (BOM:524748) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Link Pharma Chem's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=39.10/76
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Link Pharma Chem was 0.95. The lowest was 0.37. And the median was 0.57.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Link Pharma Chem Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Link Pharma Chem's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Link Pharma Chem (BOM:524748) Business Description

Industry
Traded in Other Exchanges
N/A
Address
161 - 162, GIDC Estate, Nandesari Industrial Estate, Nandesari, Vadodara, GJ, IND, 391340
Link Pharma Chem Ltd is a chemical manufacturing company in India. The company is engaged in the manufacturing and exporting of multi-range intermediates for pharmaceuticals, agro-industries, and specialty chemicals. It is also engaged in custom synthesis/contract manufacturing for multistage synthesis for a range of companies. It operates through one single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.

Link Pharma Chem (BOM:524748) Headlines

No Headlines